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With the reports of Stevenson et al1 and Blaisdell2
in 1961, the use of the descending thoracic aorta as
an alternative inflow source for the treatment of aor-
toiliac occlusive disease was introduced. Bypass graft-
ing from the descending thoracic aorta to the iliac or
femoral arteries initially was used as a remedial recon-
struction for aortic graft failure, graft infection, or
other intra-abdominal catastrophes. These early expe-
riences were on the basis of sporadic case reports3-10
and small patient series.11-15 More recent studies,
including those from our institution, have established
a role for descending thoracic aorta to iliofemoral
bypass grafting for secondary reconstruction on the
basis of low perioperative morbidity and mortality
rates and on reasonable long-term patency rates.16-22
Unfortunately, most of these studies lack adequate
follow-up periods or sufficient numbers of patients to
give statistical power to long-term results.
Although descending thoracic aorta to iliofemoral
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basis of this report.
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complete occlusion (21 patients) and severe atherosclerotic disease (10 patients) of the
infrarenal aorta. The indications for 19 secondary revascularizations (38%) were prior
aortic or extra-anatomic graft failure in 17 cases and aortic graft infection in 2 cases. The
follow-up periods ranged from 1 to 150 months (mean, 39 months). The cumulative
life-table 5-year primary patency, secondary patency, limb salvage, and survival rates
were 79%, 84%, 93%, and 67%, respectively. An improved patency trend was observed for
patients who underwent operation for severe claudication as compared with limb-threat-
ening ischemia (92% and 69%; P = .07). However, there was no difference between pri-
mary and secondary operations in primary patency rates (81% and 79%; P = NS) or sur-
vival rates (72% and 62%; P = NS).
Conclusion: Descending thoracic aorta to iliofemoral artery bypass grafting has excellent
overall long-term results. These results support its more liberal use for primary revas-
cularization, especially for patients with severe atherosclerotic disease or complete occlu-
sion of the infrarenal aorta. (J Vasc Surg 1999;29:249-58.)
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artery bypass grafting as a secondary reconstruction is
well described, its role as a primary procedure remains
controversial. Because of our favorable experience
with this operation for secondary reconstruction,18,21
the use of descending thoracic aorta to iliofemoral
artery bypass grafting has been expanded in recent
years to include selected patients in whom a primary
conventional aortofemoral operation is less than opti-
mal. Such situations include patients with severe ath-
erosclerotic disease or complete occlusion of the
infrarenal aorta and with anatomic constraints that
preclude a direct aortic approach.23
The purpose of this study was to report the over-
all long-term results on the basis of a 15-year experi-
ence with 50 descending thoracic aorta to iliofemoral
artery bypass grafting procedures performed at the
same institution. The study also compared the results
for primary and secondary operations.
PATIENTS AND METHODS
Patients who underwent bypass grafting from the
descending thoracic aorta to the iliac or femoral arter-
ies for aortoiliac occlusive disease at the University of
North Carolina from January 1, 1983, to December
31, 1997, were identified from our vascular surgery
registry. Associated medical conditions, surgical indi-
cations, and prior vascular operations were reviewed
from hospital records.
Before operation, the patients underwent nonin-
vasive lower extremity arterial examination to docu-
ment the severity of ischemia on the basis of seg-
mental pressures, waveform analysis, and femoral
artery acceleration time.24 A complete angiography
of the aortoiliac and lower extremity vessels was per-
formed with standard techniques before all the pro-
cedures. An additional angiography of the descend-
ing thoracic aorta was performed to assess the ade-
quacy of the distal segment as an inflow source in
the earlier portion of the series but has not been rou-
tinely performed in more recent years. Pulmonary
function tests and baseline arterial blood gas mea-
surements were obtained only in the patients with
suspected limited pulmonary reserve, with docu-
mented severe pulmonary disease a potential con-
traindication to the procedure.
Descending thoracic aorta to iliofemoral artery
bypass grafting constituted a primary operation in
patients without previous direct aortoiliac or extra-
anatomic reconstructions. Patients were selected for
primary repair by the operating surgeon if the fol-
lowing characteristics were present: (1) severe ather-
osclerotic disease or complete occlusion of the
infrarenal aorta and relative contraindications to
direct aortic reconstruction (ie, prior intra-abdomi-
nal sepsis, multiple abdominal operations, radiation,
or colostomy), and (2) severe atheroscerotic disease
or complete occlusion of the infrarenal aorta in which
the descending thoracic aorta was the preferred
source of inflow by the operating surgeon on the
basis of the severity of the occlusive disease of the
infrarenal aortic segment. Descending thoracic aorta
to iliofemoral artery bypass grafting was considered a
secondary procedure if performed in the presence of
a previous failed or infected aortofemoral or extra-
anatomic bypass graft.
Our surgical technique for bypass grafting from
the descending thoracic aorta to the iliac or femoral
arteries has been previously described in detail.18,21,25
After the administration of general anesthesia and the
placement of a double-lumen endotracheal tube, the
patient was positioned with the pelvis flat and the left
thorax elevated 45 to 60 degrees to a right lateral
decubitus position. Bilateral groin incisions were made
to allow exposure of the femoral vessels. The left groin
incision was extended cephalad 5 to 10 cm. With the
inguinal ligament intact, the oblique and transversus
muscles were divided parallel to the direction of the
muscle fibers and the left retroperitoneal space was
entered. For alternate exposure of the external or com-
mon iliac arteries, an oblique suprainguinal approach
could have been used. A crossover tunnel was made
between the left retroperitoneal space and the right
groin, posterior to the rectus muscle and anterior and
cephalad to the bladder. A left posterolateral muscle-
sparing thoracotomy was performed through the
eighth or ninth intercostal space. The descending tho-
racic aorta was exposed, and a site with minimal ather-
osclerotic disease was selected for anastomosis. After
mobilization of the diaphragm from its posterior
attachments, the retroperitoneal tunnel was extended
between the left suprainguinal preperitoneal space and
left hemithorax, posterior to the kidney along the
psoas muscle. A partially occluding aortic clamp was
used for control of the distal descending thoracic
aorta, and proximal anastomosis was performed to a
bifurcated Dacron graft in an end-to-side fashion. The
graft was tunneled as described previously, and distal
anastomoses were performed between each limb of the
graft and either the iliac or femoral arteries. A thora-
costomy tube was placed in the left pleural space, and
all the incisions were closed. After surgery, all the
patients are admitted to the intensive care unit and
undergo treatment with epidural pain control and with
mechanical ventilation when necessary.
Operative technical data, including graft config-
uration, concomitant procedures, duration of opera-
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tion, and estimated blood loss, were recorded, with
comparisons made between primary and secondary
repair. Postoperative hospital course, including need
for prolonged mechanical ventilation, duration of
intensive care unit stay, length of hospitalization,
and postoperative complications, also were reviewed
and compared.
The patients were seen by one of the authors for
follow-up visits in the initial postoperative period,
every 3 to 6 months for the first year, and annually
thereafter. Graft patency was assessed at each visit with
clinical and noninvasive vascular examination, and
suspected graft occlusions were confirmed with color-
flow duplex ultrasound scanning or arteriography.
Long-term primary patency rates, secondary
patency rates, limb salvage rates, and survival rates
were determined with life-table analysis as defined
by the recommended reporting standards.26 The
failure of either limb of the graft was considered to
be the failure of the entire graft. The patency rates
were calculated on the basis of the number of grafts,
limb salvage rates on the basis of the number of
limbs at risk, and survival rates on the basis of the
number of patients. Comparisons between patients
who underwent primary and secondary descending
thoracic aorta to iliofemoral bypass grafting were
made with the c 2 test for comparing proportions,
the Student t test for comparing means, and the log-
rank test for life-table analysis (P < .05 for statistical
significance).
RESULTS
Fifty patients underwent bypass grafting from the
descending thoracic aorta to the iliac or femoral arter-
ies during the 15-year period. The population had a
mean age of 57.2 ± 9.9 years (range, 33 to 83 years)
and included 19 men (38%) and 31 women (62%).
Primary versus secondary operation. Of the
50 descending thoracic aorta-to-iliofemoral artery
bypass grafting procedures, 31 (62%) were per-
formed as a primary procedure. These procedures
included 21 (68%) for complete infrarenal aortic
occlusion and 10 (32%) for severe atherosclerotic
disease of the infrarenal aorta. The unfavorable
abdominal conditions that contributed to the selec-
tion of operation included prior intra-abdominal
surgery in 14 cases, prior radiation in two cases, pre-
vious intra-abdominal sepsis in two cases, and
anatomic constraints in the presence of a horseshoe
kidney in one case. The remaining 11 patients
underwent primary repair as the preferred approach
only on the basis of the severity of the infrarenal aor-
tic occlusive disease.
The indications for 19 secondary revasculariza-
tions (38%) were prior failed aortic or extra-anatomic
grafts in 17 cases and aortic graft infections in two
cases. Initial aortoiliac revascularization in these 19
patients included 12 direct aortic procedures (10 aor-
tic grafts, two aortoiliac endarterectomies) and seven
extra-anatomic bypass grafting procedures (two
iliofemoral, two femoral-femoral, three axillob-
ifemoral) with relative contraindications to a direct
aortic approach. An average of 6.1 ± 3.9 years elapsed
between the initial operation and the placement of the
secondary descending thoracic aorta-to-iliofemoral
bypass graft. During this time, an additional 25 oper-
ations had been performed in these 19 patients before
the descending thoracic aorta-to-iliofemoral artery
bypass grafting. These salvage operations included the
placement of extra-anatomic grafts after the failed aor-
tic graft (four axillofemoral and two femoral-femoral),
the attempted salvage of a previous aortic or extra-
anatomic bypass graft (10 graft thrombectomy, three
aortic graft revisions, and four extra-anatomic graft
revisions), and the removal of the infected graft mate-
rial (two aortic graft excisions).
Clinical presentation. There was no statistical
difference between primary and secondary repair in
mean age, gender distribution, or associated medical
conditions, including tobacco use, diabetes mellitus,
heart disease, stroke, chronic pulmonary disease,
chronic renal failure, or previous intra-abdominal
surgery. These conditions are summarized in Table I. 
The surgical indications are shown in Table II.
Limb-threatening ischemia was present in nine
patients (29%) who underwent a primary procedure
as compared with 17 (89%) who underwent a sec-
ondary revascularization (P < .001). Severe claudica-
tion was a more frequent indication for primary
repair and represented 22 operations (71%) as com-
pared with two (11%) for secondary bypass grafting
procedures (P < .001).
Type of operation. Of the 50 bypass grafting
operations that were performed, 39 (78%) were of a
bifemoral configuration, four (8%) were bi-iliac, four
(8%) were unifemoral, and three (6%) were per-
formed with one limb to the iliac artery and the other
limb to the femoral artery. The descending thoracic
aorta was adequate for inflow in all the operations,
with 49 of the grafts (98%) originating from the dis-
tal segment and one (2%) from the mid-segment.
Seven patients (14%) underwent concomitant proce-
dures that included infrainguinal bypass grafting in
four cases, renal artery bypass grafting in two cases,
and mesenteric artery bypass grafting in one case
through an extended retroperitoneal exposure.25
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The mean operative time was 320 ± 70 minutes
(range, 240 to 440 minutes) when descending tho-
racic aorta-to-iliofemoral artery bypass grafting was
performed alone, with more time necessary for the
operations with concomitant procedures (mean, 440
± 130; P < .05). Although a similar operative time
was necessary for primary repair (340 ± 95 minutes)
and secondary repair (362 ± 80 minutes; P = NS),
the operative blood loss was significantly less for pri-
mary repair (520 ± 340 mL) than for secondary
repair (805 ± 390 mL; P < .01).
Perioperative morbidity and mortality rates.
Thirty-three patients (66%) underwent extubation in
the operating room, with 17 (34%) requiring post-
operative ventilatory support for a mean of 4.3 ± 7.9
days (range, 1 to 25 days). Of these 17 patients, 13
underwent extubation by the second postoperative
day. Prolonged ventilatory support (>1 week) was
required in only three patients (6%). The mean inten-
sive care unit stay was 5.2 ± 7.3 days (range, 1 to 33
days), with 36 patients (72%) requiring 3 days or less.
The resumption of oral intake occurred, on the aver-
age, 4.1 ± 1.2 days after the surgery. The mean hos-
pital stay was 11.1 ± 9.3 days, with 36% of the
patients discharged within 1 week, 72% within 10
days, and 88% within 2 weeks. There were no statis-
tical differences between primary and secondary
repair for the duration of mechanical ventilation, the
length of the intensive care unit stay, the resumption
of oral intake, or the length of hospitalization.
Two perioperative deaths (one from myocardial
infarction, one from mesenteric infarction) occurred,
which yielded an overall operative mortality rate of 4%.
Major postoperative complications occurred in eight
patients (16%), including pulmonary failure in three
patients, myocardial infarction in two patients, mesen-
teric infarction in two patients, and stroke in one
patient. Seven additional wound complications (super-
ficial infection, hematoma, or lymphocele; 14%) also
occurred. Although two patients had mesenteric
infarction, both cases occurred late in the postopera-
tive period, with nonocclusive mesenteric ischemia in
one patient and probable cardiac embolization after
new onset atrial fibrillation in the other. No patients
had renal failure or required hemodialysis, and only
one patient had a postoperative elevation of creatinine
that was greater than 1.0 above the preoperative level.
Although one patient had a postoperative stroke, there
was no neurologic compromise related to spinal cord
ischemia. No statistical difference in complication rates
was observed between primary and secondary repair.
Patency. Follow-up periods ranged from 1 to
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Table I. Associated medical conditions in patients who underwent primary and secondary descending 
thoracic aorta-to-iliofemoral bypass grafting
Primary (n = 31) Secondary (n = 19) Overall (n = 50) P*
Mean age (years) 58.2 ± 10.0 55.2 ± 9.9 57.2 ± 9.9 NS
Gender
Male 12 (39%) 7 (37%) 19 (38%) NS
Female 19 (61%) 12 (63%) 31 (62%) NS
Tobacco use 24 (77%) 15 (79%) 39 (78%) NS
Hypertension 16 (51%) 11 (57%) 27 (54%) NS
Cardiac disease 10 (32%) 5 (26%) 15 (30%) NS
Hyperlipidemia 8 (26%) 4 (21%) 12 (24%) NS
Diabetes mellitus 4 (13%) 2 (10%) 6 (12%) NS
Stroke 3 (10%) 1 (5%) 4 (8%) NS
Pulmonary disease 3 (10%) 1 (5%) 4 (8%) NS
Renal failure 0 0 0 NS
Prior intra-abdominal surgery† 13 (42%) 6 (31%) 19 (38%) NS
*c 2 test for proportions and Student t test for comparison of means between primary and secondary operations.
†Excluding prior vascular operations.
Table II. Indications for primary and secondary descending thoracic aorta-to-iliofemoral bypass grafts
Primary (n = 31) Secondary (n = 19) Overall (n = 50) P*
Claudication 22 (71%) 2 (11%) 24 (48%) <.001
Rest pain 8 (26%) 14 (74%) 22 (44%) <.01
Ulceration 1 (3%) 3 (16%) 4 (8%) NS*
c
2 test comparing primary and secondary operations.
150 months (mean, 39 ± 29 months). Primary
patency was lost in 10 descending thoracic aorta-to-
iliofemoral grafts (20%) because of single limb occlu-
sion in six cases, graft infection in two cases, com-
plete graft occlusion in one case, and distal graft
pseudoaneurysm necessitating repair in one case.
Overall, the life-table primary patency rate at 5
years for descending thoracic aorta-to-iliofemoral
artery bypass grafting procedures was 79% (Table
III). There was no significant difference in the 5-
year patency rate between primary and secondary
repairs (81% and 79%, respectively; P = NS; Fig 1).
However, an improved patency trend was observed
for the patients who underwent operation for severe
claudication as compared with limb-threatening
ischemia (92% and 69%, respectively; P = .07; Fig 2).
Nine additional procedures were performed for
failed descending thoracic aorta-to-iliofemoral
bypass grafts, including four graft extensions, three
revisions with thrombectomy, and two grafts treated
with thrombolytic catheter-directed therapy. This
increased the overall secondary patency rate to 84%
at 5 years (Table IV).
Additional operative intervention also was neces-
sary in the two patients with descending thoracic
aorta-to-iliofemoral bypass graft infections. The sur-
gical management included the removal of an infect-
ed femoral limb at the level of the groin, with obtu-
rator bypass grafting from a proximal portion of the
ipsilateral femoral limb to the distal profunda
femoral artery and the removal of both femoral
limbs, leaving a thoracic noninfected portion of graft
with conversion to axillobifemoral bypass grafting. 
Limb salvage. Twenty-six patients (40 limbs)
underwent descending thoracic to iliofemoral artery
bypass grafting for limb salvage indications. During
the follow-up period, four of these limbs were ampu-
tated in three patients at intervals of 1, 26, 48, and
50 months after surgery. Two of these amputations
were associated with descending thoracic aorta-to-
iliofemoral bypass graft occlusion, one with graft
infection, and one after infrainguinal vein graft occlu-
sion. There were no amputations in the patients who
originally underwent operation for severe claudica-
tion. The overall life-table limb salvage rate for the
grafts that were performed for limb-threatening
ischemia was 93% (Table V). Because of the limited
numbers of limbs at risk, a valid comparison between
primary and secondary procedures was not possible.
Late mortality. The overall 5-year survival rate
by life-table analysis was 67% (Table VI), with no
statistical difference between primary and secondary
repairs (72% and 62%, respectively; P = NS). In addi-
tion to the two perioperative deaths, nine late deaths
occurred during the follow-up period and were
unrelated to the descending thoracic aorta-to-
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Fig 1. Life-table primary patency rates for primary and secondary descending thoracic aorta-
to-iliofemoral bypass grafts (P = NS with log-rank test).
iliofemoral bypass grafting operation. The causes of
the late deaths were from cardiac disease in three
cases, malignant disease in two cases, stroke in one
case, and an unknown reason in three cases.
DISCUSSION
This study represents a 15-year experience with
50 descending thoracic aorta-to-iliofemoral artery
bypass grafts that were performed at a single institu-
tion and represents the largest published experience
to date. As compared with our previously published
experience,18,21 there are now enough patients with
follow-up of adequate duration to report the long-
term results. In this study, the cumulative life-table
5-year primary patency, secondary patency, limb sal-
vage, and survival rates were 79%, 84%, 93%, and
67%, respectively. These cumulative results also are
similar to the results from a meta-analysis, which was
performed in our previous study on 146 patients
from several combined series, in which the primary
patency, secondary patency, and survival rates were
73%, 83%, and 68%, respectively.21
Bypass grafting from the descending thoracic to
iliac or femoral arteries traditionally has been reserved
for patients with aortic graft failure or infection or as
an alternative procedure when a direct transabdomi-
nal aortic approach is not feasible. Despite use as a
remedial operation, previously published results have
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Fig 2. Life-table primary patency rates of descending thoracic aorta-to-iliofemoral bypass grafts
for patients with severe claudication as compared with limb-threatening ischemia (P = .07 with
log-rank test).
Table III. Overall life-table primary patency rates of descending thoracic aorta-to-iliofemoral bypass grafts
(n = 50)
No. of patients No. of occluded No. of withdrawn Interval patency Cumulative
Period (months) at risk grafts grafts rates patency rates SE
0 to 1 50 1 2 0.98 0.98 0.02
2 to 6 47 1 3 0.98 0.96 0.03
7 to 12 43 1 6 0.98 0.93 0.04
13 to 24 36 3 7 0.91 0.85 0.06
25 to 36 26 0 5 1 0.85 0.06
37 to 48 21 0 5 1 0.85 0.07
49 to 60 16 1 2 0.93 0.79 0.09
SE, Standard error.
been satisfactory, with patency rates that ranged from
76% to 86% at 5 years.16-22 In our experience,
descending thoracic aorta-to-iliofemoral artery bypass
grafting had been the preferred method of secondary
revascularization for aortic graft failure or infection,
with a reported 5-year primary patency rate of 79% in
this series. These long-term results are comparable
with those results reported for reoperative transab-
dominal aortic reconstruction27-32 and are more con-
sistent than those results reported for axillofemoral
bypass grafting for which the patency rate has varied
from 10% to 75%.33-38
Although the role of descending thoracic aorta-to-
iliofemoral artery bypass grafting is well established as
a secondary procedure, its use as a primary operation
is controversial. In selected patients in whom unfavor-
able abdominal conditions (eg, prior multiple abdom-
inal surgeries, radiation, or intraabdominal sepsis)
make the approach to the infrarenal aorta difficult, pri-
mary descending thoracic aorta-to-iliofemoral artery
bypass grafting is a better option. What remains more
controversial is the use of the descending thoracic
aorta as the primary inflow for patients with severe ath-
erosclerotic disease or complete occlusion of the
infrarenal aorta. In this study, the life-table primary
patency rate at 5 years for primary repair with descend-
ing thoracic aorta-to-iliofemoral artery bypass grafting
was 81%, which compares favorably with an 83% to
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Table V. Overall life-table limb salvage rates for descending thoracic aorta-to-iliofemoral bypass grafts (n = 40)
No. of patients No. of No. of withdrawn Interval limb Cumulative limb
Period (months) at risk amputations grafts salvage rates salvage rates SE
0 to 1 40 0 2 1 1 0
2 to 6 38 1 2 0.97 0.97 0.03
7 to 12 35 0 2 1 0.97 0.03
13 to 24 33 0 5 1 0.97 0.03
25 to 36 28 1 5 0.96 0.97 0.05
37 to 48 22 0 2 1 0.93 0.05
49 to 60 20 0 3 1 0.93 0.05 
SE, Standard error.
Table IV. Overall life-table secondary patency rates of descending thoracic aorta-to-iliofemoral bypass
grafts (n = 50)
No. of patients No. of occluded No. of withdrawn Interval patency Cumulative
Period (months) at risk grafts grafts rates patency rates SE
0 to 1 50 1 2 0.98 0.98 0.02
2 to 6 47 1 3 0.98 0.96 0.03
7 to 12 43 0 6 1 0.96 0.03
13 to 24 37 1 8 0.97 0.93 0.04
25 to 36 28 1 3 0.96 0.89 0.06
37 to 48 24 0 7 1 0.89 0.07
49 to 60 17 1 2 0.94 0.84 0.08
SE, Standard error.
Table VI. Overall life-table survival rates for descending thoracic aorta-to-iliofemoral bypass grafts (n = 50)
No. of patients No. of withdrawn Interval Cumulative
Period (months) at risk No. of deaths grafts survival rates survival rates SE
0 to 1 50 2 1 0.96 0.96 0.03
2 to 6 47 0 3 1 0.96 0.03
7 to 12 44 0 8 1 0.96 0.03
13 to 24 36 2 6 0.94 0.90 0.05
25 to 36 28 1 5 0.96 0.87 0.06
37 to 48 22 3 5 0.85 0.73 0.08
49 to 60 14 1 4 0.92 0.67 1
SE, Standard error.
92% patency rate for standard aortofemoral bypass
grafting in most historical series.39-43
However, these historical series must be viewed in
perspective because most patients who underwent
revascularization for aortoiliac occlusive disease with
direct aortofemoral bypass grafting several decades
ago had less severe atherosclerotic disease and a lower
prevalence of limb-threatening ischemia. In this
study, the patients who underwent repair for severe
claudication had an improved patency trend as com-
pared with those patients who underwent operation
for limb salvage (92% and 69%, respectively; P = NS).
Although most primary operations were performed
for severe claudication, atherosclerotic disease in the
infrarenal aorta was more advanced, with a higher
proportion of patients with complete aortic occlusion
than in prior cumulative aortofemoral series.39-43
Published reports on the use of direct aortic repair
for infrarenal aortic occlusion are few and lack long-
term follow-up, which makes further comparison dif-
ficult.44-47 Regardless, the long-term results of
descending thoracofemoral and direct aortofemoral
bypass grafting for complete infrarenal aortic occlu-
sion when stratified appropriately seem to be equiva-
lent, as we have previously reported.23
Conceptually, the long-term patency rate for pri-
mary repair should be better than the rate for sec-
ondary repair. However, in this study, there was no sig-
nificant difference between primary and secondary
operations in primary patency rates (81% and 79%,
respectively; P = NS) or survival rates (72% and 62%,
respectively; P = NS). Although the patients who
underwent primary repair more commonly underwent
operation for severe claudication (71% and 11%,
respectively; P < .001), this did not translate to an
improved patency rate for the primary operative
group. This lack of difference reflects the effect of
comparing a smaller number of patients after stratifica-
tion, and yet, it should be noted that comorbid factors
were similar between both groups—except that the
patients who underwent secondary repair more com-
monly had undergone a prior vascular operation.
Furthermore, in this study, most patients who under-
went secondary repair also underwent operation 
for aortic graft occlusion and not graft infection.
Remedial operation with descending thoracic aorta-
to-iliofemoral artery bypass grafting for graft infection
may have poorer results than for graft occlusion as sug-
gested by Sapienza et al,22 although this has not been
confirmed by others.16,17,19,20
The use of the descending thoracic aorta as an
inflow source for primary aortoiliac reconstruction
has a number of advantages over conventional direct
aortic repair. First, the descending thoracic aorta
typically has minimal atherosclerotic disease, which
makes it more suitable for proximal anastomosis
than the infrarenal aorta.48 Early in our experience,
we routinely obtained angiograms of the distal
descending aorta. Because of the minimal athero-
sclerotic disease at this level, angiography of the
descending thoracic aorta is no longer routinely per-
formed to avoid the increased risk of additional con-
trast. Despite this change, the distal descending tho-
racic aorta has remained adequate for inflow in all of
the cases, with only one patient requiring anastomo-
sis to a mid-segment. Second, in this study, descend-
ing thoracic aorta-to-iliofemoral artery bypass graft-
ing was performed with a 4% operative mortality rate
and a 16% major complication rate, which is compa-
rable with aortofemoral bypass grafting.39-43 The
thoracic approach and the use of a partially occlud-
ing aortic clamp for the proximal anastomosis main-
tain spinal cord, mesenteric, and renal blood flow. As
a result, there was no spinal cord ischemia or renal
failure in this series, and although two patients had
mesenteric infarction, these infarctions were unrelat-
ed to surgical technique. Finally, the retroperitoneal
location of the graft avoids unfavorable intra-
abdominal conditions, and the placement of the
proximal anastomosis in the chest further eliminates
the potential for aortoenteric fistula.
The proposed mechanism for infrarenal aortic
occlusion is that of iliac and distal aortic atheroscle-
rotic disease progression and subsequent infrarenal
aortic thrombosis, with outflow to the renal arteries
maintaining patency of the suprarenal aorta. Several
reports have raised concern for proximal aortic
thrombus propagation manifested as renal dysfunc-
tion or mesenteric compromise.49,50 Although we
did not routinely obtain follow-up aortic imaging to
assess for suprarenal propagation of thrombus after
descending thoracic to iliofemoral bypass grafting,
late renal failure did not develop in any of the
patients and the episodes of perioperative mesenteric
infarction were explained by other factors. Other evi-
dence has confirmed that proximal thrombus pro-
gression rarely occurs when infrarenal aortic inter-
ruption is accompanied by remote bypass grafting,
except in the presence of renal or visceral lesions.47,51
In conclusion, descending thoracic aorta-to-
iliofemoral artery bypass grafting has excellent over-
all long-term results. This supports its continued use
as an alternative procedure for aortic graft failure or
infection. A more liberal use for primary revascular-
ization also should be considered for patients with
severe atherosclerotic disease or complete occlusion
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of the infrarenal aorta, especially when a direct trans-
abdominal aortic approach is not feasible.
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Dr Walter J. McCarthy III (Chicago, Ill). The authors
have brought to our attention a 15-year review of thora-
cofemoral bypass grafting. Their presentation is the largest
series of this type of operation ever compiled from a single
institution since Dr Lester Sauvage and William Blaisdell
published case reports of this operation in two separate
papers in 1961. This paper is similar to other previous large
series, except that about two thirds of the cases were for
primary indications when previously most series used this
operation for complicated cases that could not be recon-
structed in other ways. The overall morbidity and mortali-
ty rates were quite acceptable for such a complicated oper-
ation. I have several questions with a comment beforehand.
I speak as an advocate of this operation, which has been
popular at Northwestern for more than 20 years. We pre-
sented our first report of this series in 1983 and then updat-
ed it with as presentation to The International Society for
Cardiovascular Surgery 5 years ago in 1993. In addition, we
will show a video whereby the thoracic portion of this oper-
ation can be completed without a standard thoracotomy
with a thoracoscope. This is to say that I am an enthusiastic
proponent of the thoracofemoral bypass graft. My comment
is that we should always try to use the simplest technique to
achieve long-term patency for our patients. My first question
relates to this. Is the thoracofemoral bypass graft really the
best and least complicated way of achieving revascularization
when faced with a standard infrarenal aortic occlusion? In
most of our hands, infrarenal aortic occlusion is managed
fairly simply with a standard transabdominal approach.
The second question relates to infection. Do the
authors use this operation at the same sitting as the
removal of an infected intra-abdominal aortic graft? We
have always used an axillary femoral bypass graft and then
converted it to a thoracofemoral bypass graft if that was
necessary months or years later.
In the manuscript, the authors mention several infec-
tions of these grafts, and I wondered how they dealt with
the infected grafts. Have they removed them from the
thorax, and did they have to patch the thoracic aorta?
Finally, have the authors ever reoperated on an occlud-
ed graft with a second thoracotomy when thrombectomy
or lytic therapy was unsuccessful?
Dr Marc A. Passman. Thank you, Dr McCarthy, for
your thoughtful comments.
The first question concerned whether this operation
should replace the standard aortofemoral operation. I do
not want to leave the impression that we are advocating
this operation as a replacement. Clearly, aortofemoral
operation has withstood the test of time with many larger
published series and with an excellent long-term outcome.
Rather, we would like to advocate thoracofemoral bypass
grafting as a reasonable alternative in certain situations. In
patients with complete aortic occlusion, we use thora-
cofemoral bypass grafting as a preferred method of treat-
ment over standard aortofemoral bypass grafting.
The second question concerned the use of thora-
cofemoral bypass grafting for infection. That only repre-
sented two patients in the entire series. Other series have
had more experience with thoracofemoral bypass grafting
for aortic graft infection. It is difficult to say whether the
long-term outcome is lessened by the fact that an infected
aortic or extra-anatomic bypass graft is present. However,
we think it is a reasonable alternative to other remedial
operations, such as axillofemoral bypass grafting for such
situations. As far as our graft infection rate, there were
only two patients in whom graft infections developed.
Most of the infections were localized to the groin, and we
did not have to replace the entire thoracic bypass graft.
Your last question concerned reoperation for a com-
pletely occluded graft. We have not typically reoperated
for completely occluded thoracofemoral bypass grafts with
thoracotomy, and, at that point, we will preferentially use
axillofemoral or some other form of extra-anatomic bypass
graft.
And as a final comment, we also await your presenta-
tion concerning the thoracoscopic approach. We do have
some reservations with that in terms of aortic control but
are interested in your video presentation. Thank you.
DISCUSSION
